Latest / The BioHub - by Avetix
Episode 65 - Robert Ross - CEO of Clasp Therapeutics
We were delighted to welcome Robert Ross, Chief Executive Officer at Clasp Therapeutics, onto The BioHub. Clasp Therapeutics are a pioneering biotech company spearheading the next generation of T-cell engager therapies. Founded in 2024 and backed by a successful $150 million Series A round with top tier investors, Clasp stands out for its novel approach in delivering off-the-shelf, bispecific T‐cell engagers that narrowly target cancer-driving mutations while sparing healthy tissues. Dr. Ross brings a wealth of experience to Clasp’s mission. Before stepping into the CEO role at Clasp in…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.